Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge  Lars Harder Christensen, PhD,

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Detection of novel occupational wood allergens in locust wood dust (Robinia pseudoacacia L.)  Sabine Kespohl, PhD, Rolf Merget, MD, Axel Overlack, MD,
Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns  Christian S. Hansen, PhD, Martin Dufva,
Allergen immunotherapy: A practice parameter third update
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Margaretha A. Faber, MD, Vito Sabato, MD, Chris H
Advances in food allergy in 2015
Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns  Christian S. Hansen, PhD, Martin Dufva,
Is 9 more than 2 also in allergic airway inflammation?
Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity  Jens Holm, PhD, Nicholas Willumsen,
Safety of allergen immunotherapy: A 10-year prospective study
The enigma of IgE+ B-cell memory in human subjects
Molecular determinants of allergen-induced effector cell degranulation
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions  Maria José Torres, MD, PhD,
A network-based analysis of the late-phase reaction of the skin
Nonadherence to Asthma Treatment: Getting Unstuck
Etiology of asthma exacerbations
The future of allergy/immunology: Promising young investigators
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Identification of bee venom Api m 1 IgE epitopes and characterization of corresponding mimotopes  Abida Zahirović, MPharm, Ana Koren, PhD, Peter Kopač,
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors  Donald W. MacGlashan, MD, PhD,
Respiratory sensitization of a worker to the warehouse beetle Trogoderma variabile: An index case report  Jonathan A. Bernstein, MD, Marjorie S. Morgan,
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom  Jörg Fischer, MD, Martin Teufel, MD, Alexandra.
Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen- specific immunotherapy  Roberto González-Rioja, PhD, Ignacio Ibarrola,
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Peanut T-cell epitope discovery: Ara h 1
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Allergenic significance of cephalosporin side chains
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen  Sonia de Halleux, MSc, Enrico.
Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: Major conformational IgE epitopes blocked by prodomains 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Cockroach allergens: Coping with challenging complexity
Oktay Kirak, MD, Gert Riethmüller, MD 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy.
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Geographic variability in childhood asthma prevalence in Chicago
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?  Marianne Witten, MD, PhD, Hans-Jørgen Malling, MD, Lars.
Clinical consequences of defects in B-cell development
The discovery of IgE Journal of Allergy and Clinical Immunology
Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab  Donald W. MacGlashan,
Prevention of food allergy: Beyond peanut
Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients  Takaaki Hiragun, MD, PhD, Kaori Ishii, MSc, Makiko Hiragun, MD, Hidenori.
Mechanisms of allergen-specific desensitization
Reply Journal of Allergy and Clinical Immunology
TH9 immunodeficiency in patients with hyper-IgE syndrome
Innate immune responses to infection
Macrolide antibiotics and asthma treatment
Cure of HIV infection: Is the long wait over?
Asthma: The past, future, environment, and costs
Genetic regulation of IgE responses: Achilles and the tortoise
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven.
Environmental factors and eosinophilic esophagitis
The GILL study: Glycerin-induced local reactions in immunotherapy
Evolution of IgE responses to multiple allergen components throughout childhood  Rebecca Howard, MSc, Danielle Belgrave, PhD, Panagiotis Papastamoulis,
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Negative affect, medication adherence, and asthma control in children
The effects of gastric digestion on codfish allergenicity
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
The Editors' Choice Journal of Allergy and Clinical Immunology
Quantitative computed tomographic imaging–based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes  Sanghun Choi, PhD,
Presentation transcript:

Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge  Lars Harder Christensen, PhD, Jens Holm, PhD, Gitte Lund, Erik Riise, PhD, Kaare Lund, PhD  Journal of Allergy and Clinical Immunology  Volume 122, Issue 2, Pages 298-304 (August 2008) DOI: 10.1016/j.jaci.2008.05.026 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Der p 2 epitope mapping. Principle (A), examples (B), and summary (C) of results obtained by means of relative epitope-mapping experiments by using surface plasmon resonance are shown. Principle (D), example (E), and summary (F) of results obtained by means of epitope-mapping experiments with rDer p 2 variants by using surface plasmon resonance are shown. G and H, Three- and 2-dimensional maps of Der p 2 epitopes bound by the rIgE clones. Source of Der p 2 structure: Derewenda et al13; PDB ID, 1KTJ. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 IgE affinities for rDer p 2. A-C, Examples of affinity determinations of rIgE clones binding rDer p 2 with high, medium, and low affinity, respectively, as obtained by using surface plasmon resonance experiments. Only the relevant part from where rDer p 2 is injected is shown. D, Summary of affinities obtained of all rIgE clones (color coded according to the epitope specificities marked in Fig 1, G and H). Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Basophil degranulation at different concentrations of total rIgE. FACS results of human basophils sensitized with total rIgE concentrations of 3, 1, 0.2, 0.04, 0.008, and 0.0016 μg/mL, respectively, are shown. The composition of the rIgE mixture was kept constant with 20% rDer p 2–specific rIgE consisting of equimolar quantities (6.67% each) of 3 rIgE clones (G, H10, and H12) recognizing nonoverlapping Der p 2 epitopes and 80% non–Der p 2–specific rIgE (anti-tox). Upper left, Schematic representation of Der p 2 epitope specificity and affinity of rIgE clones G, H10, and H12; analog to Figs 1, H, and 2, D. H, High affinity; M, medium affinity; L, low affinity. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Basophil degranulation at different concentrations of Der p 2–specific rIgE relative to non–Der p 2–specific rIgE. FACS results of human basophils sensitized with different concentrations of Der p 2–specific rIgE (srIgE) relative to non–Der p 2–specific rIgE (non-srIgE) are shown. The composition of the rIgE mixtures consisted of equimolar quantities of 3 rIgE clones (E, H10, and H12) recognizing nonoverlapping Der p 2 epitopes and variable concentrations of non–Der p 2–specific rIgE (anti-tox). The total rIgE concentration was kept constant at 1 μg/mL. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Basophil degranulation at different ratios between 2 Der p 2–specific rIgE clones. FACS results of human basophils sensitized with different ratios of 2 Der p 2–specific rIgE clones (E and H12) are shown. All other parameters were kept constant; that is, the total concentration of rIgE was 1 μg/mL, and the relative concentrations were 20% Der p 2–specific to 80% non–Der p 2–specific rIgE. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Basophil degranulation at different rIgE affinity combinations. FACS results of human basophils sensitized with different combinations of 2 rIgE clones having different affinities for rDer p 2 are shown. All other parameters were kept constant; that is, rIgE clones were directed against the same 2 epitope clusters, the total IgE concentration was 1 μg/mL, the relative concentrations were 20% Der p 2–specific to 80% non–Der p 2–specific rIgE, and equimolar concentrations of the 2 Der p 2–specific rIgE clones were used. H, High affinity; M, medium affinity; L, low affinity. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 7 Basophil degranulation at different rIgE clonalities. FACS results of human basophils sensitized with combinations of 1, 2, or 3 rIgE clones binding nonoverlapping Der p 2 epitopes are shown. All other parameters were kept constant; that is, the total IgE concentration was 1 μg/mL, the relative concentrations were 20% Der p 2–specific to 80% non–Der p 2–specific rIgE, and equimolar concentrations of the rDer p 2–specific rIgE clones were used. Journal of Allergy and Clinical Immunology 2008 122, 298-304DOI: (10.1016/j.jaci.2008.05.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions